BEYOND AIR INC. - COMMON STOCK

0,3736

08-января-25 12:40:32

15 мин. задержка

Акции

-0,0364

-8,88%

Сегодняшний диапазон

0,3562 - 0,4300

ISIN

N/A

Источник

NASDAQ

Beyond Air® Schedules Second Fiscal Quarter 2023 Financial Results Conference Call and Webcast

20 окт 2022 15:05:00 Источник Nasdaq GlobeNewswire
Beyond Air® Announces Positive Data from At-Home Pilot Study in Patients with Refractory NTM Lung Infection Treated with (NO) using the LungFit® GO at the CHEST Annual Meeting 2022

17 окт 2022 15:05:00 Источник Nasdaq GlobeNewswire
Beyond Cancer™ to Present Pre-Clinical Data for Ultra-High Concentration Nitric Oxide Therapy at the 2022 SITC Annual Meeting

05 окт 2022 07:00:01 Источник Nasdaq GlobeNewswire
Beyond Air® Announces that Annals of the American Thoracic Society Published a Review of the Third Pilot Study of High Dose Nitric Oxide for Bronchiolitis

03 окт 2022 06:30:00 Источник Nasdaq GlobeNewswire
Beyond Air® To Participate in Three Upcoming Investor Conferences

16 сен 2022 15:05:00 Источник Nasdaq GlobeNewswire
Beyond Air® Affiliate Beyond Cancer™ Doses Initial Patient in First-in-Human Phase 1 Study of Ultra-High Concentration Nitric Oxide Therapy at Tel Aviv Sourasky Medical Center (Ichilov)

23 авг 2022 07:00:01 Источник Nasdaq GlobeNewswire
Beyond Air® Reports Financial Results for the First Quarter of Fiscal Year 2023

11 авг 2022 15:05:02 Источник Nasdaq GlobeNewswire
Beyond Air® Schedules First Fiscal Quarter 2023 Financial Results Conference Call and Webcast

27 июл 2022 15:05:01 Источник Nasdaq GlobeNewswire
Beyond Air® Reports Financial Results for Fourth Fiscal Quarter and Year-End 2022

28 июн 2022 15:10:00 Источник Nasdaq GlobeNewswire
Beyond Air’s LungFit® PH Receives FDA Approval to Treat Term and Near-Term Neonates with Hypoxic Respiratory Failure

28 июн 2022 15:05:00 Источник Nasdaq GlobeNewswire
Beyond Air® Announces Fiscal Year End 2022 Financial Results Conference Call and Webcast Moved to Tuesday, June 28th

14 июн 2022 15:30:00 Источник Nasdaq GlobeNewswire
Beyond Cancer™ Announces the Appointment of Jedidiah Monson, M.D. to Chief Medical Officer

01 июн 2022 06:00:01 Источник Nasdaq GlobeNewswire
Beyond Air® Presents Positive Study Update from the At-Home LungFit® GO Pilot Study for Nontuberculous Mycobacterial Lung Disease at the American Thoracic Society International Conference 2022

17 май 2022 15:05:00 Источник Nasdaq GlobeNewswire
Beyond Cancer, Ltd. Appoints Susan Howell Jones, CPA as Chief Financial Officer

17 май 2022 06:00:02 Источник Nasdaq GlobeNewswire
Beyond Air® Schedules Fiscal Year 2022 Financial Results Conference Call and Webcast

16 май 2022 06:05:00 Источник Nasdaq GlobeNewswire
Beyond Air® Reports Positive Long-Term Safety Data for High Concentration Inhaled Nitric Oxide in Bronchiolitis at the Pediatric Academic Societies Meeting 2022

25 апр 2022 15:05:00 Источник Nasdaq GlobeNewswire
Beyond Air® Presents Positive Safety and Efficacy Data for Inhaled Nitric Oxide to Treat COVID-19 at ECCMID 2022

25 апр 2022 06:00:01 Источник Nasdaq GlobeNewswire
Beyond Air® to Participate in Three Upcoming Medical Conferences

18 апр 2022 06:00:00 Источник Nasdaq GlobeNewswire
Beyond Cancer™ Announces New Preclinical Data Presented at American Association for Cancer Research (AACR) Showing Ultra-High Concentration Nitric Oxide Therapy Anti-Tumor Effect

11 апр 2022 06:00:00 Источник Nasdaq GlobeNewswire
Beyond Cancer™ to Present Two Abstracts for Ultra-High Concentration Nitric Oxide Therapy at the 2022 AACR Annual Meeting

08 мар 2022 15:35:00 Источник Nasdaq GlobeNewswire

<<
<
1
2
3
4
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.